Yesterday, June 1, 2016, 85 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $11.31 to $40,830,885.00.

Highlighted Stocks Traded by Insiders:

Medifast (MED) - FREE Research Report

Visium Balanced Master Fund, Ltd., who is 10% Owner at Medifast, sold 1.4 million shares at $30.25 on June 1, 2016. Following this transaction, the 10% Owner owned 0 shares meaning that the stake was reduced by 100% with the 1.4 million-share transaction.

The shares most recently traded at $32.48, up $2.23, or 6.88% since the insider transaction. Historical insider transactions for Medifast go as follows:

  • 4-Week # shares sold: 8,333
  • 12-Week # shares sold: 8,333
  • 24-Week # shares sold: 33,332

The average volume for Medifast has been 136,500 shares per day over the past 30 days. Medifast has a market cap of $378.0 million and is part of the services sector and specialty retail industry. Shares are up 7.64% year-to-date as of the close of trading on Wednesday.

Medifast, Inc., through its subsidiaries, produces, distributes, and sells weight loss, weight management, healthy living products, and other consumable health and diet products. The stock currently has a dividend yield of 3.13%. The company has a P/E ratio of 19.5. Currently, there are no analysts who rate Medifast a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MED - FREE

TheStreet Quant Ratings

rates Medifast as a

buy

. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, solid stock price performance and expanding profit margins. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Medifast Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Inventure Foods (SNAK) - FREE Research Report

Lapadat Paul J, who is Director at Inventure Foods, bought 7,000 shares at $7.25 on June 1, 2016. Following this transaction, the Director owned 20,119 shares meaning that the stake was boosted by 53.36% with the 7,000-share transaction.

The shares most recently traded at $7.94, up $0.69, or 8.69% since the insider transaction. Historical insider transactions for Inventure Foods go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 6,055
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 15,991
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 15,991

The average volume for Inventure Foods has been 114,300 shares per day over the past 30 days. Inventure Foods has a market cap of $146.9 million and is part of the consumer goods sector and food & beverage industry. Shares are up 7.75% year-to-date as of the close of trading on Wednesday.

Inventure Foods, Inc. manufactures and markets healthy/natural and indulgent specialty snack food products in the United States and internationally. It operates in two segments, Frozen Products and Snack Products. Currently, there are 5 analysts who rate Inventure Foods a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SNAK - FREE

TheStreet Quant Ratings

rates Inventure Foods as a

sell

. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk, disappointing return on equity, poor profit margins, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full

Inventure Foods Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Uni-pixel (UNXL) - FREE Research Report

Young Ross Adam, who is Director at Uni-pixel, bought 4,000 shares at $1.71 on June 1, 2016. Following this transaction, the Director owned 26,800 shares meaning that the stake was boosted by 17.54% with the 4,000-share transaction.

The shares most recently traded at $1.65, down $0.06, or 3.64% since the insider transaction. Historical insider transactions for Uni-pixel go as follows:

  • 4-Week # shares bought: 29,400
  • 4-Week # shares sold: 8,500
  • 12-Week # shares bought: 29,400
  • 12-Week # shares sold: 8,500
  • 24-Week # shares bought: 29,400
  • 24-Week # shares sold: 8,500

The average volume for Uni-pixel has been 1.3 million shares per day over the past 30 days. Uni-pixel has a market cap of $67.5 million and is part of the technology sector and electronics industry. Shares are up 223.7% year-to-date as of the close of trading on Wednesday.

Uni-Pixel, Inc. designs, develops, manufactures, and markets micro-structured polymer film materials and related technologies for the display, flexible electronics, and automotive industries in the United States. Currently, there is 1 analyst who rates Uni-pixel a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on UNXL - FREE

TheStreet Quant Ratings

rates Uni-pixel as a

sell

. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity and generally disappointing historical performance in the stock itself. Get the full

Uni-pixel Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.